SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022
- PMID: 36516380
- PMCID: PMC9755951
- DOI: 10.2105/AJPH.2022.307112
SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021‒2022
Erratum in
-
Erratum In: "SARS-CoV-2 Infection, Hospitalization, and Death in Vaccinated and Infected Individuals by Age Groups in Indiana, 2021-2022".Am J Public Health. 2023 May;113(5):586. doi: 10.2105/AJPH.2022.307112e. Epub 2023 Mar 16. Am J Public Health. 2023. PMID: 36926970 Free PMC article. No abstract available.
Abstract
Objectives. To assess the effectiveness of vaccine-induced immunity against new infections, all-cause emergency department (ED) and hospital visits, and mortality in Indiana. Methods. Combining statewide testing and immunization data with patient medical records, we matched individuals who received at least 1 dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines with individuals with previous SARS-CoV-2 infection on index date, age, gender, race/ethnicity, zip code, and clinical diagnoses. We compared the cumulative incidence of infection, all-cause ED visits, hospitalizations, and mortality. Results. We matched 267 847 pairs of individuals. Six months after the index date, the incidence of SARS-CoV-2 infection was significantly higher in vaccine recipients (6.7%) than the previously infected (2.9%). All-cause mortality in the vaccinated, however, was 37% lower than that of the previously infected. The rates of all-cause ED visits and hospitalizations were 24% and 37% lower in the vaccinated than in the previously infected. Conclusions. The significantly lower rates of all-cause ED visits, hospitalizations, and mortality in the vaccinated highlight the real-world benefits of vaccination. The data raise questions about the wisdom of reliance on natural immunity when safe and effective vaccines are available. (Am J Public Health. 2023;113(1):96-104. https://doi.org/10.2105/AJPH.2022.307112).
Figures
Similar articles
-
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35085222 Free PMC article.
-
Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.MMWR Morb Mortal Wkly Rep. 2021 Nov 19;70(46):1608-1612. doi: 10.15585/mmwr.mm7046a4. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34793417 Free PMC article.
-
Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization.BMC Med. 2022 Mar 17;20(1):119. doi: 10.1186/s12916-022-02321-4. BMC Med. 2022. PMID: 35296305 Free PMC article.
-
Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department.J Clin Microbiol. 2022 Mar 16;60(3):e0239021. doi: 10.1128/jcm.02390-21. Epub 2022 Jan 19. J Clin Microbiol. 2022. PMID: 35044204 Free PMC article.
-
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.PLoS Med. 2021 Dec 17;18(12):e1003874. doi: 10.1371/journal.pmed.1003874. eCollection 2021 Dec. PLoS Med. 2021. PMID: 34919548 Free PMC article.
Cited by
-
The impact of comorbidity status in COVID-19 vaccines effectiveness before and after SARS-CoV-2 omicron variant in northeastern Mexico: a retrospective multi-hospital study.Front Public Health. 2024 Jun 12;12:1402527. doi: 10.3389/fpubh.2024.1402527. eCollection 2024. Front Public Health. 2024. PMID: 38932780 Free PMC article.
-
Non-uptake of COVID-19 vaccines and reasons for non-uptake among healthcare workers in Uganda: a cross-sectional study.BMC Health Serv Res. 2024 May 25;24(1):663. doi: 10.1186/s12913-024-11137-2. BMC Health Serv Res. 2024. PMID: 38796411 Free PMC article.
-
Vaccination Shortens the Negative Nucleic Acid Conversion Time of the Older Population: A Retrospective Cohort Study of 73,456 Asymptomatic and Mild Patients with COVID-19 in Shanghai.Int J Gen Med. 2024 Mar 4;17:763-773. doi: 10.2147/IJGM.S451393. eCollection 2024. Int J Gen Med. 2024. PMID: 38463436 Free PMC article.
-
Waning effectiveness of mRNA COVID-19 vaccines against inpatient and emergency department encounters.PLoS One. 2024 Mar 7;19(3):e0300198. doi: 10.1371/journal.pone.0300198. eCollection 2024. PLoS One. 2024. PMID: 38452010 Free PMC article.
-
Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines.Vaccines (Basel). 2024 Jan 6;12(1):57. doi: 10.3390/vaccines12010057. Vaccines (Basel). 2024. PMID: 38250870 Free PMC article. Review.
References
-
- Bajema KL, Dahl RM, Prill MM, et al. Effectiveness of COVID-19 mRNA vaccines against COVID-19-associated hospitalization—five Veterans Affairs medical centers, United States, February 1‒ August 6, 2021. MMWR Morb Mortal Wkly Rep. 2021;70(37):1294–1299. doi: 10.15585/mmwr.mm7037e3. - DOI - PMC - PubMed
-
- Grannis SJ, Rowley EA, Ong TC, et al. Interim estimates of COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance—nine states, June‒August 2021. MMWR Morb Mortal Wkly Rep. 2021;70(37):1291–1293. doi: 10.15585/mmwr.mm7037e2. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
